# Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/impact-of-disease-progression-on-health-related-quality-of-life-of-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dana M. Chase,Margarita Romeo Marín,Floor Backes,Sileny Han,Whitney A. Spannuth Graybill,Mansoor Raza Mirza,Bhavana Pothuri,Giorgia Mangili,David M. O’Malley,Dominique Berton,Lyndsay Willmott,Klaus Baumann,Robert L. Coleman,Tamar Safra,Viola Heinzelmann‐Schwarz,Domenica Lorusso,Florian M. Karl,Tatia Woodward,Bradley J. Monk,Antonio González-Martı́n |
| Citations | 19 |
| DOI | 10.1016/j.ygyno.2022.06.028 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.gynecologiconcology-online.net/article/S0090825822004322/pdf |
| OpenAlex ID | https://openalex.org/W4285603620 |
| PMID | 35851489 |
| Type | article |
| Year | 2022 |

## Paper authors

- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Robert L. Coleman](https://scholariq.org/researchers/robert-l-coleman/)
- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)
- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)

## Paper funders

- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)

## Paper journal

- [Gynecologic Oncology](https://scholariq.org/journals/gynecologic-oncology/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.